News archive
2007
20-Dec-2007
AngioChem Secures US $3 Million in Financing from MMV Financial, Inc. MORE...
6-Dec-2007
1st patient dosed at MD Anderson, Houston, TX, in Phase 1/2
clinical study testing ANG1005 in the treatment of primary (glioblastoma) and metastatic
brain tumors
24-Oct-2007
AngioChem announces IND clearance from the US FDA for its lead
product, ANG1005, for the treatment of brain cancer. More...
14-Sep-2007
AngioChem files IND for a Phase 1/2 study evaluating ANG1005 in patients with brain
metastasis and recurrent glioblastoma.
17-Apr-2007
AngioChem had successful Pre-IND meeting with FDA for ANG1005.
2005
12-Dec-2005
AngioChem Completes a $6 Million Financing to Advance CNS
Drug Development. More...